Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
주식 순위 #20515
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
주가
$20.38
시가총액
$129.09M
변동 (1일)
-0.82%
변동 (1년)
80.91%
국가
PL
거래 Captor Therapeutics Spolka Akcyjna (CTX)

카테고리

Captor Therapeutics Spolka Akcyjna (CTX)의 주가 이력
최고 종가: $20.25 (2026-08-01 기준)

최저 종가: $45.81 (2021-04-01 기준)
Captor Therapeutics Spolka Akcyjna의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -1.92%
2025 68.95%
2024 -54.45%
2023 -32.61%
2022 -15.45%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$766.29 8.42%
CH